USA - NASDAQ:YDES - KYG983011076 - Common Stock
The current stock price of YDES is 17.41 USD. In the past month the price decreased by -24.66%.
YD Bio Ltd is a TW-based company operating in industry. The company is headquartered in Taipei City, Taipei. The company went IPO on 2025-08-29. YD Bio Ltd is a Taiwan-based company principally engaged in pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. The Company’s core areas include non-invasive cancer detection tools for early diagnosis and monitoring, ophthalmologic products targeting dry eye conditions, and exosome-based therapeutics aimed at treating complex diseases. By integrating cutting-edge science with accessible solutions, YD Bio strives to improve patient outcomes and quality of life.
YD BIO LTD
2F, No.3, Xingnan Street, Nangang District
Taipei City TAIPEI TW
Employees: 0
Phone: 88623820330
The current stock price of YDES is 17.41 USD. The price decreased by -6.95% in the last trading session.
The exchange symbol of YD BIO LTD is YDES and it is listed on the Nasdaq exchange.
YDES stock is listed on the Nasdaq exchange.
YD BIO LTD (YDES) has a market capitalization of 1.22B USD. This makes YDES a Small Cap stock.
YD BIO LTD (YDES) currently has 0 employees.
YD BIO LTD (YDES) has a support level at 17.06 and a resistance level at 18.6. Check the full technical report for a detailed analysis of YDES support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
YDES does not pay a dividend.
YD BIO LTD (YDES) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).
The outstanding short interest for YD BIO LTD (YDES) is 0.13% of its float. Check the ownership tab for more information on the YDES short interest.
ChartMill assigns a technical rating of 3 / 10 to YDES.
ChartMill assigns a fundamental rating of 1 / 10 to YDES. Both the profitability and financial health of YDES have multiple concerns.
Over the last trailing twelve months YDES reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS increased by 3.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -78.08% | ||
ROE | N/A | ||
Debt/Equity | N/A |